Denali Therapeutics
DNLI
DNLI
209 hedge funds and large institutions have $2.49B invested in Denali Therapeutics in 2023 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 72 increasing their positions, 68 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 194 → 209 (+15)
4.89% more ownership
Funds ownership: 79.06% → 83.95% (+4.9%)
6% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 68
Holders
209
Holding in Top 10
6
Calls
$1.82M
Puts
$1.48M
Top Buyers
| 1 | +$35.8M | |
| 2 | +$26M | |
| 3 | +$20.9M | |
| 4 |
BlackRock
New York
|
+$14.1M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$13.8M |
Top Sellers
| 1 | -$14M | |
| 2 | -$12.8M | |
| 3 | -$12.3M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$11.9M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$9.02M |